Dr Lindsay Rosenwald | Lindsay Rosenwald Success & Achievements

As is among the most respected business people within the field of biotechnology, Dr. Lindsay Rosenwald’s countless contributions to that industry is as the Founder and Chairman of a Group of Companies. These kinds of projects consist of a company that helps to facilitate and synchronize drug development and corporate development pursuits, a global pharmaceutical drug development and health care investment organization specializing in the conception, nurturing, and assistance of new biotechnology firms. Also boosting its numerous portfolio companies is a listed broker-dealer with Financial Industry Regulatory Authority, Inc., or FINRA.

After graduating from Abington High School in southeastern Pennsylvania in 1973, Dr. Rosenwald went to Pennsylvania State University as a Finance major. He graduated as a member of Beta Gamma Sigma, an extremely regarded and acclaimed honor society, then proceeded to study at Temple University’s School of Medicine. After completing his studies at Temple, Dr. Rosenwald went into private practice where he continued until 1986. At that time, he relocated to Wall Street to serve as a physician/financial expert, a specialized mixture of career fields that not many boasted at that time.

Dr. Lindsay Rosenwald has revolutionized the field of bioresearch and biotechnology. One of his portfolio firms hold the record for a drug, Arsenic Trioxide, moving most quickly from development to Food & Drug Administration acceptance. Yet another of his firms, Cougar Biotechnology, was bought by J&J in 2009 mainly due to their work with abiraterone acetate. This drug wasn’t yet in stage III medical tests for its application in the management of prostate cancer but was so promising that Johnson & Johnson purchased the company in a “short-term merger” for around $1 billion. It’s intriguing to take note, Abiraterone acetate is founded on Traditional Chinese Medicine practices. Aside from providing initial funds to a lot of of today’s most notable bio-tech companies, Dr. Rosenwald also supports many charities and institutions though the Rosenwald Foundation, of which he’s the chairman. His generous gifts provide the means for scientists to develop the medications for the future.

With all of his different knowledge and qualifications, Dr. Rosenwald leads the world in cutting edge research and development in the bio-tech field. It is because of his special combination of education and knowledge in the finance and bio-tech world that he can incorporate experiences from both fields and build distinctive new experiences. There are very few people on the globe that can match Dr. Rosenwald’s impressive achievements in such a highly specialized field.

Dr. Lindsay Rosenwald, does work with that unit of businesses which is mostly connected with investment money managing, asset supervision, plus direct investing and venture capital in the life-science and biotechnological business. One organization utilizes a amalgamation of U.S. based and also foreign hedge funds and also private equity for the purpose of managing their investor assets. In addition to that Dr. Lindsay Rosenwald possesses an association with the Managing Member of Orion Biomedical Fund, LP and the Orion Biomedical Offshore Fund, LP. Both of these organizations are helping in Financing. Over the course of more than 20 years, Dr. Lindsay Rosenwald has collaborated as a Wall Street entrepreneur in biotechnology. He has initiated and re-capitalized many private and public life-sciences and biotechnology businesses. The portfolio establishments have so far crafted three new chemical agents that have been permitted by the FDA and they at the current moment have a large number of compounds that are even still undergoing clinical trials. One such portfolio company named PolaRx BioPharmaceuticals, Inc., has been granted a final marketing endorsement for a leukemia product recognized as arsenic trioxide. This was concluded only 30 months, an industry highest achievement, after the therapy of the very first testees was finished in a corporate clinical assessment. 5 Other than Cougar Biotechnology, Dr. Lindsay Rosenwald has additionally taken it upon himself to either pay for or originate such companies as Bradley Pharmaceuticals, Inc., Repligen Corporation, Avigen, Inc., Cardiome Pharma Corp., Neose Technologies Inc., Biocryst Pharmaceuticals, Inc, Cypress Bioscience, Inc., Genta, Inc, Discovery Laboratories, Inc., Indevus Pharmaceuticals, Inc., Keryx Biopharmaceuticals, Inc., Cell Therapeutics, Inc., and Hudson Health Sciences, Inc.

In relation to his educational background, Dr. Lindsay Rosenwald was a graduate of Abington High School, in the southeast area of Pennsylvania, back in 1973. The future business man and doctor proceeded to graduate Beta Gamma Sigma with a degree in Finance and Economy from Pennsylvania State University in 1977. Afterwards, he discovered employment as an independent management consultant, laboring for various health care businesses during the years 1977 to 1979 and then entering himself into the Temple University School of Medicine. He graduated from Temple in 1983 and soon following began an internship at the Abington Medical Hospital, staying in the private medicine industry until the year 1986. Dr. Lindsay Rosenwald then moved on to Wall Street in order to mix his economic and medical skills and operate as a medical doctor/financial analyst.

Lindsay Rosenwald and His Career

Dr. Lindsay A. Rosenwald asserted himself as a corporate finance managing director for D.H. Blair & Company, in the year of 1988. This was a non public investment based business. There, he operated as the supervisor of a team of three doctor-financiers that sought through the health community for any new and profit-making advancements that could make use of private investment. They succeeded in finding various medical schools, universities, hospitals, pharmaceutical companies, study groups, and scientific firms.  Here, he worked within the biotechnology and bioresearch fields. He became a NASD-member dealer in 1992 and founded the investment and commercial bank. Owned by Dr. Lindsay A. Rosenwald, the Capital Asset Management company has directed investments from quite a few funds since 1994 that have a concentration in the biotechnology and other technological arenas. Dr. Rosenwald is a member of the Columbia-Presbyterian Health Sciences Advisory Counsel and in the 2002 article edition of Genetic Engineering News he was ranked number one in the list of 100 Molecular Millionaires having a worth of $617,721,671. Dr. Lindsay Rosenwald operated on the Keryx Biopharmaceutical, Inc board of directors from 2002 to 2006. He resigned in order to grant additional time laboring in the biotechnology area. Cougar Biotechnology, purchased by Johnson & Johnson in 2009, is another business that was originally founded by Dr. Rosenwald and was established exclusively on abiraterone acetate. Abiraterone Acetate, even though it had not yet arrived at phase III in clinical testing trials, was demonstrating so much potential in the therapy and handling for prostate cancer that Johnson & Johnson permitted a short-term merger bid and procurement  for the Cougar Biotechnology corporation for $1 billion. Dr. Lindsay Rosenwald, apart from the various ventures which have bestowed funding and assets to portfolio companies, has also established the Rosenwald Foundation. This is a nonprofit outfit that has been triumphant in offering millions of dollars in aid of countless medical and scientific instruction institutions.

Any time you think of prominent Jewish Education the primary name that most likely comes up is Sh’ or Yoshuv Institute. This Institute additionally hosts a community center that serves a congregation from the biggest Jewish communities in all of the united states. Servicing a community of close to a thousand families, the Institute is also recognized because of its Jewish outreach programs, and its special empathy for the requirements of the global Jewish community and of those individuals who walk through its beckoning doorway.

The institute is most well-known because of its Jewish Awareness and it relies on this particular hallmark characteristic in order to provide help to its group. Such sensitivity, and global interest in charitable causes, are trademarks of Dr. and Mrs. Lindsay Rosenwald, dear friends of our institute and role models for our community. As the leaders of a family dedicated to charity — as a couple whose vigor to assist those people in need of assistance is matched by their magnanimous heart and soul– the Rosenwalds are philanthropists of unique discretion and sincerity

The method the Rosenwalds parent their children is one of their most important and respected traits The Rosenwalds combine their charitable character though out their lifetime and don’t distinguish it from their home life. You could also say that the Rosenwalds private life is working away at charitable causes. So much so, they involve their own youngsters in lots of of their altruistic pursuits. Events to build knowledge for different children’s causes and fund raisers are held in their household, generally, to permit their children to learn by illustration and one day follow inside their dad’s or mom’s actions. The potential of humankind is a every day concern for the Rosenwald household. These people have a real love for the betterment of community, especially education and learning. Not often does one locate such benefactors who, in addition to the charitable contributions they furnish throughout the world, also have a primary connection with specific people requiring monetary assistance on a worldwide level.

Tales are readily available regarding Dr. Lindsay Rosenwald’s generous heart. A friend of the Doctors, who’s an artist, was the beneficiary of Dr. Rosenwald’s generosity. He procured his close friend’s work so he could redecorate the walls of the Institutes’s principal lobby. The pictures were and are wonderful , but they were ordered with the sole intent being financially assisting the painter. Yet another tale consists of the Rosenwald’s being honored at a previous Sh’or Yoshuv Annual Banquet. The doctor agreed to accept the accolade, but explained to Sh’or Yoshuv, “I don’t like the limelight, but you know I am going to do what it takes to help you out.”

Probably the most poignant account to talk about entails the Institute within a vital budget dilemma. A meeting was called to end major deficits, and happened in Dr. Rosenwald’s house. After remaining quiet throughout the whole conference, Dr. Lindsay Rosenwald approached the Rabbi, and privately whispered that he would take care of the entire deficit. He had been very sensitive to every person in the room, and required zero accolades for the kind offer he had planned all along.

The Institute is proud that the magnificent atrium of the campus is dedicated to the memory of Dr. Lindsay Rosenwald’s father, Mr. David R. Rosenwald,Esq. The Rosenwalds are dear private friends of Sh’or Yoshuv Institute, and join Sh’or Yoshuv for the High Holy Days, while also going to many other special events organized at the Institute. They are profoundly dedicated to their rich heritage, and are a fundamental element of the very foundation of support that sustains the Institute as a exciting center of Jewish education and learning. Their continued assistance is a source of inspiration to the entire administration, and a crucial connection to Sh’or Yoshuv Institutes’s upcoming success.